Helicobacter pylori infection: How and when do gastroenterologists treat themselves? A questionnaire enquiry;Helicobacter pylori - Wann und wie behandeln sich Gastroenterologen selbst? Eine Umfrage in Klinik und Praxis

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 20, 1997, Pages 637-642

  Labenz, J ^a   Malfertheiner, P ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; OMEPRAZOLE;

ADULT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DYSPEPSIA; FEMALE; GERMANY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRACTICE GUIDELINE; QUESTIONNAIRE; STOMACH ULCER;

EID: 0030958656     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047667     Document Type: Article

References (14)

1. Bayerdörffer, E., A. Morgner, A. Neubauer, B. Rudolph, C. Thiede, N. Lehn, E. Seifert, M. Frevel, A. Sommer, H. Schulz, H. Heidt, B. Geiter, P. Rohde, H. Klann, M. Stolte: Regression of primary gastric MALT lymphoma after cure of Helicobacter pylori infection: a two-year follow-up report of the German MALT lymphoma trial. Gastroenterology 110 (1996), A490.
2. Caspary, W. F., R. Arnold, E. Bayerdörffer, R. Behrens, B. Birkner, B. Braden, W. Domschke, J. Labenz, S. Koletzko, P. Malfertheiner, H. Menge, W. Rösch, W. Schepp, M. Strauch, M. Stolte: Diagnostik und Therapie der Helicobacter-pylori-Infektion. Leitlinien der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten. Z. Gastroenterol. 34 (1996) 392-401.
3. Erdag, S., J. B. Boiko, M. Burlage, R. Schwarzhoff, B. Braden, B. Lembcke, U. R. Fölsch: Optimal compliance eliminates differences in eradication rates between 2-week dual and 1-week triple therapy for Helicobacter pylori gastritis. Gastroenterology 110 (1996), A103.
4. Hopkins, R. J., L. S. Girardi, E. A. Turney: Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence. A review. Gastroenterology 110 (1996), 1244-1252.
5. Kosunen, T. U., K. Sepällä, S. Sarna, P. Sipponen: Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 339 (1992), 893-895.
6. Kuipers, E. J., L. Lundell, E. C. Klinkenberg-Knol, N. Havu, H. P. M. Festen, B. Liedman, C. B. H. W. Lamers, J. B. M. J. Jansen, J. Dallenbäck, P. Snel, F. Nelis, S. G. M. Meuwissen: Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. New Engl. J. Med. 334 (1996), 1018-1022.
7. Labenz, J., C. O'Morain: Eradication. Curr. Opin. Gastroenterol. 11 (Suppl. 1) (1995), 47-51.
8. Loffeld, R. J. L. F., W. T. J. Vriese, E. E. Stobberingh: Usefulness of several commercial enzyme-liked immunoassays for detection of Helicobacter pylori in clinical medicine. Europ. J. Gastroenterol. Hepatol. 5 (1993), 333-337.
9. Milne, R., R. P. Logan, D. Harwood, J. J. Misiewicz, D. Forman: Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom. Gut 37 (1995), 314-318.
10. 13C-urea breath test (UBT). Gastroenterology 110 (1996), A227.
11. Penston, J. G., K. R. Mistry: Eradication of Helicobacter pylori in general practice. Aliment. Pharmacol. Ther. 10 (1996), 139-145.
12. Talley, N.: A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 106 (1994), 1174-1183.
13. Vaira, D., M. Miglioli, P. Mulè J. Holton, M. Mennegatti, M. Vergura, G. Biasco, R. Conte, R. P. H. Logan, L. Barbara: Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut 35 (1994), 309-312.
14. Vallentin, J., R. Praßler, B. Wigginhaus, A. J. Dormann, H. Huchzermeyer: Wie häufig wird der Erfolg einer in der Klinik eingeleiteten Helicobacter pylori Eradikationstherapie (ET) endoskopisch überprüft? Z. Gastroenterol. 34 (Suppl. 1) (1996), 40-41.